DYRK3 and ovarian serous adenocarcinoma: Through a retrospective analysis of a substantial cohort and experimental manipulations of serous ovarian cancer cell lines, we aim to elucidate the correlation between DYRK3 expression, prognosis, and the underlying mechanisms influencing tumor behavior to offer a comprehensive exploration of DYRK3's potential as a prognostic marker and therapeutic target in serous ovarian cancer.